With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
In one of the few wins among recent Ebola epidemics, Merck is now claiming their vaccine V920 is proving to be over 90% effective on the front lines of the current outbreak in the Democratic Republic of the Congo. | Branswell, STAT News 2019